---
title: "Trinity Biotech Ltd (530573) — Share Price, Financials & Analysis"
symbol: "530573"
company: "Trinity Biotech Ltd"
canonical: "https://tapetide.com/stocks/530573"
isin: "INE785B01016"
bse_code: "530573"
generated_at: "2026-10-13T11:01:13.944Z"
---

# Trinity Biotech Ltd (530573)

Canonical page: https://tapetide.com/stocks/530573

## Company

- **BSE Code:** 530573
- **ISIN:** INE785B01016
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** trinitygroup.ind.in

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
- Company has high debtors of 15,215 days.

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | -171% |
| revenue growth | -49% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 44.05 | 32.95 | 36.95 | 25.76 | 13.38 | 1.5 | 0.46 | 0.67 | 0.04 | 0 | 0.35 | 0.06 |
| Expenses | 50.11 | 31.87 | 34.86 | 25.95 | 36.09 | 18.91 | 3.11 | 1.41 | 87.15 | 0.64 | 0.8 | 0.86 |
| Operating Profit | -6.06 | 1.08 | 2.09 | -0.19 | -22.71 | -17.41 | -2.65 | -0.74 | -87.11 | -0.64 | -0.45 | -0.8 |
| OPM % | -13.76 | 3.28 | 5.66 | -0.74 | -169.73 | -1160.67 | -576.09 | -110.45 | -217775 | — | -128.57 | -1333.33 |
| Other Income | -0.18 | 0.63 | 0.07 | 0 | 0.64 | 0.02 | 0.02 | -8.01 | 0 | 0.01 | 0.04 | 0 |
| Interest | 4.64 | 4.45 | 4.5 | 4.4 | 2.47 | 0.42 | 23.95 | 18.16 | -0.75 | 0 | 0 | 0 |
| Depreciation | 0.87 | 0.64 | 0.67 | 0.65 | 0.63 | 0.69 | 0.73 | 0.72 | 0.89 | 0.47 | 0.63 | 0.57 |
| Profit before tax | -11.75 | -3.38 | -3.01 | -5.24 | -25.17 | -18.5 | -27.31 | -27.63 | -87.25 | -1.1 | -1.04 | -1.37 |
| Tax % | -34.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -7.74 | -3.38 | -3.01 | -5.24 | -25.17 | -18.5 | -27.31 | -27.63 | -87.25 | -1.1 | -1.04 | -1.37 |
| EPS in Rs | -3.54 | -1.55 | -1.38 | -2.4 | -11.53 | -8.47 | -12.51 | -12.65 | -39.95 | -0.5 | -0.48 | -0.63 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 |
| --- | --- | --- |
| Sales | 0.37 | 0.19 |
| Expenses | 0.06 | 0.3 |
| Operating Profit | 0.31 | -0.11 |
| OPM % | 83.78 | -57.89 |
| Other Income | 0 | 0 |
| Interest | 0 | 0 |
| Depreciation | 0.07 | 0.06 |
| Profit before tax | 0.24 | -0.17 |
| Tax % | 0 | 0 |
| Net Profit | 0.24 | -0.17 |
| EPS in Rs | 0.72 | -0.51 |
| Dividend Payout % | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 |
| --- | --- | --- |
| Equity Capital | 3.33 | 3.33 |
| Reserves | -3.12 | -3.29 |
| Borrowings | 9.97 | 10.24 |
| Other Liabilities | 5.07 | 5.69 |
| Total Liabilities | 15.25 | 15.97 |
| Fixed Assets | 0.35 | 0.01 |
| CWIP | 0 | 0 |
| Investments | 2.12 | 2.06 |
| Other Assets | 12.78 | 13.9 |
| Total Assets | 15.25 | 15.97 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 |
| --- | --- | --- |
| Cash from Operating Activity | — | -0.62 |
| Cash from Investing Activity | — | 0.36 |
| Cash from Financing Activity | — | 0.27 |
| Net Cash Flow | — | 0.01 |
| Free Cash Flow | — | -0.34 |
| CFO/OP | — | 564 |

### Ratios

| Item | Mar 2006 | Mar 2007 |
| --- | --- | --- |
| Debtor Days | 7063.24 | 15214.74 |
| Cash Conversion Cycle | 7063.24 | 15214.74 |
| Working Capital Days | 7586.08 | 15714.21 |
| ROCE % | — | -1.66 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Jun 2021 |
| --- | --- | --- | --- | --- | --- | --- |
| Promoters | 53.62% | 48.9% | 28.37% | 28.37% | 28.37% | 28.37% |
| DIIs | 0.05% | 0.05% | 19.62% | 19.29% | 19.24% | 19.24% |
| Public | 46.34% | 51.05% | 52.01% | 52.34% | 52.4% | 52.4% |
| No. of Shareholders | 9135 | 10256 | 10187 | 10091 | 9965 | 10038 |

### Quarterly

| Category | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 48.89% | 28.37% | 28.37% | 28.37% | 28.37% | 28.37% | 28.37% | 28.37% | 28.37% | 28.37% | 28.37% | 28.37% |
| DIIs | 0.05% | 20.58% | 19.62% | 19.29% | 19.29% | 19.38% | 19.29% | 19.24% | 19.24% | 19.24% | 19.24% | 19.24% |
| Public | 51.06% | 51.05% | 52.01% | 52.34% | 52.34% | 52.26% | 52.34% | 52.4% | 52.4% | 52.4% | 52.4% | 52.4% |
| No. of Shareholders | 10202 | 10218 | 10187 | 10160 | 10154 | 10111 | 10091 | 10079 | 10006 | 9936 | 9965 | 10038 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 24.55 | Sell |
| EMA (10) | 24.45 | Sell |
| SMA (20) | 25.31 | Sell |
| EMA (20) | 24.92 | Sell |
| SMA (50) | 25.43 | Sell |
| EMA (50) | 25.58 | Sell |
| SMA (100) | 26.6 | Sell |
| EMA (100) | 26.43 | Sell |
| SMA (200) | 27.73 | Sell |
| EMA (200) | 28.14 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 36.41 | Neutral |
| MACD (12,26,9) | -0.51 | Sell |
| Stochastic (14,3,3) | 15.85 | Buy |
| ADX (14) | 15.37 | Neutral |
| Williams %R (14) | -81.21 | Buy |
| ATR (14) | 1.28 | High Volatility |
| ROC (12) | -7.87 | Sell |
| Stoch RSI (14) | 21.9 | Neutral |
| UO (7,14,28) | 35.13 | Neutral |

## Filings & Documents

### Annual Reports

| Date | Document |
| --- | --- |
| 2019 | [Financial Year 2019](https://www.bseindia.com/bseplus/AnnualReport//68463509148.pdf) |
| 2018 | [Financial Year 2018](https://www.bseindia.com/bseplus/AnnualReport//5091480318.pdf) |
| 2017 | [Financial Year 2017](https://www.bseindia.com/bseplus/AnnualReport//5091480317.pdf) |
| 2016 | [Financial Year 2016](https://www.bseindia.com/bseplus/AnnualReport//5091480316.pdf) |
| 2015 | [Financial Year 2015](https://www.bseindia.com/bseplus/AnnualReport//5091480315.pdf) |
| 2014 | [Financial Year 2014](https://www.bseindia.com/bseplus/AnnualReport//5091480314.pdf) |
| 2010 | [Financial Year 2010](https://www.bseindia.com/bseplus/AnnualReport//5091480310.pdf) |

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2025-09-26 | Credit rating update — CRISIL |
| 2024-07-16 | Credit rating update — CRISIL |
| 2023-05-31 | Credit rating update — CRISIL |
| 2022-03-30 | Credit rating update — CRISIL |
| 2021-01-30 | Credit rating update — CRISIL |
| 2019-10-16 | Credit rating update — CRISIL |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:01:13.944Z.